Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
GraphWear Technologies
GraphWear scores $20.5M for needle-free continuous glucose monitoring platform
By
Emily Olsen
|
11:59 am |
October 05, 2021
The funding will help the company grow its team and go through clinical trials.
New DreamIt class targets epilepsy, cancer, concussions, and more
By
Jonah Comstock
|
10:29 am |
July 15, 2015
Philadelphia-based digital health accelerator DreamIt Health has announced its third class.
